ImmuCell Corporation Interest Expense
ImmuCell Corporation (ICCC) reported Interest Expense of $144.14 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-11-13
- ImmuCell Corporation interest expense for the quarter ending 2024-09-30 was $144.14K, a 0.33% decline year-over-year.
- ImmuCell Corporation interest expense for the quarter ending 2024-06-30 was $142.39K, a 60.75% increase year-over-year.
- ImmuCell Corporation interest expense for the quarter ending 2024-03-31 was $146.00K, a 62.25% increase year-over-year.
- ImmuCell Corporation interest expense for the quarter ending 2023-12-31 was $152.42K, a 62.75% increase year-over-year.
- ImmuCell Corporation interest expense for fiscal 2023 was $475.60K, a 36.46% increase from fiscal 2022.
- ImmuCell Corporation interest expense for fiscal 2022 was $348.54K, a 10.87% increase from fiscal 2021.
- ImmuCell Corporation interest expense for fiscal 2021 was $314.36K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $144.14K 10-Q · filed 2024-11-13 | $286.53K derived: sum of 2 quarters · filed 2024-11-13 | $432.53K 10-Q · filed 2024-11-13 | $584.95K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $142.39K 10-Q · filed 2024-08-13 | $288.39K 10-Q · filed 2024-08-13 | $440.81K derived: sum of 3 quarters · filed 2024-08-13 | $585.43K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $146.00K 10-Q · filed 2024-05-14 | $298.42K derived: sum of 2 quarters · filed 2024-05-14 | $443.04K derived: sum of 3 quarters · filed 2024-11-13 | $531.62K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $152.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $297.04K derived: sum of 2 quarters · filed 2024-11-13 | $385.61K derived: sum of 3 quarters · filed 2024-11-13 | $475.60K 10-K · filed 2024-04-01 |
| 2023-09-30 | $144.62K 10-Q · filed 2024-11-13 | $233.19K derived: sum of 2 quarters · filed 2024-11-13 | $323.18K 10-Q · filed 2024-11-13 | $416.83K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $88.58K 10-Q · filed 2024-08-13 | $178.56K 10-Q · filed 2024-08-13 | $272.21K derived: sum of 3 quarters · filed 2024-08-13 | $361.64K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $89.98K 10-Q · filed 2024-05-14 | $183.64K derived: sum of 2 quarters · filed 2024-05-14 | $273.07K derived: sum of 3 quarters · filed 2024-05-14 | $363.31K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $93.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $183.08K derived: sum of 2 quarters · filed 2024-04-01 | $273.32K derived: sum of 3 quarters · filed 2024-04-01 | $348.54K 10-K · filed 2024-04-01 |
| 2022-09-30 | $89.43K 10-Q · filed 2023-11-13 | $179.67K derived: sum of 2 quarters · filed 2023-11-13 | $254.88K 10-Q · filed 2023-11-13 | $331.67K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $90.24K 10-Q · filed 2023-08-10 | $165.45K 10-Q · filed 2023-08-10 | $242.24K derived: sum of 3 quarters · filed 2023-08-10 | $320.76K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $75.21K 10-Q · filed 2023-05-11 | $152.00K derived: sum of 2 quarters · filed 2023-05-11 | $230.52K derived: sum of 3 quarters · filed 2023-05-11 | $309.94K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $76.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $155.31K derived: sum of 2 quarters · filed 2023-03-29 | $234.72K derived: sum of 3 quarters · filed 2023-03-29 | $314.36K 10-K · filed 2023-03-29 |
| 2021-09-30 | $78.53K 10-Q · filed 2022-11-21 | $157.94K derived: sum of 2 quarters · filed 2022-11-21 | $237.58K 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $79.42K 10-Q/A · filed 2022-11-21 | $159.05K 10-Q/A · filed 2022-11-21 | ||
| 2021-03-31 | $79.64K 10-Q/A · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |